PubRank

K Chwalisz

Author PubWeight™ 52.61‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Endometrial progesterone receptors and markers of uterine receptivity in the window of implantation. Fertil Steril 1996 1.58
2 Effect of placental tissue on inhibition of uterine contraction by nitric oxide donors. Am J Obstet Gynecol 1999 1.41
3 Control and assessment of the uterus and cervix during pregnancy and labour. Hum Reprod Update 1999 1.39
4 Studies on the mechanisms of action of progesterone antagonists. J Steroid Biochem 1986 1.22
5 Instrumentation for the diagnosis of term and preterm labour. J Perinat Med 1998 1.20
6 The effects of the selective progesterone receptor modulator asoprisnil on the morphology of uterine tissues after 3 months treatment in patients with symptomatic uterine leiomyomata. Hum Reprod 2007 1.14
7 Physiological dilation of uteroplacental arteries in the guinea pig depends on nitric oxide synthase activity of extravillous trophoblast. Cell Tissue Res 1995 1.11
8 Characterization of the functional progesterone receptor in an endometrial adenocarcinoma cell line (Ishikawa): progesterone-induced expression of the alpha1 integrin. J Steroid Biochem Mol Biol 1996 1.04
9 Pre-eclampsia-like conditions produced by nitric oxide inhibition: effects of L-arginine, D-arginine and steroid hormones. Hum Reprod 1995 1.03
10 Progesterone antagonists increase androgen receptor expression in the rhesus macaque and human endometrium. J Clin Endocrinol Metab 2001 1.00
11 Luminal and glandular endometrial epithelium express integrins differentially throughout the menstrual cycle: implications for implantation, contraception, and infertility. Am J Reprod Immunol 1996 0.98
12 Endocrine pharmacological characterization of progesterone antagonists and progesterone receptor modulators with respect to PR-agonistic and antagonistic activity. Steroids 2000 0.93
13 Differential regulation of nitric oxide in the rat uterus and cervix during pregnancy and labour. Hum Reprod 1996 0.91
14 The nitric oxide pathway in pre-eclampsia: pathophysiological implications. Hum Reprod Update 1998 0.90
15 Roles of potassium channels and nitric oxide in modulation of uterine contractions in rat pregnancy. Am J Obstet Gynecol 1999 0.89
16 Nitric oxide synthase distribution during implantation in the mouse. Mol Hum Reprod 1999 0.89
17 Changes in transcripts encoding calcium channel subunits of rat myometrium during pregnancy. Am J Physiol 1995 0.89
18 Studies of cervical ripening in pregnant rats: effects of various treatments. Mol Hum Reprod 2000 0.89
19 Efficacy and safety of leuprolide acetate 6-month depot for suppression of testosterone in patients with prostate cancer. Prostate Cancer Prostatic Dis 2011 0.89
20 Modulation of the action of chorionic gonadotropin in the baboon (Papio anubis) uterus by a progesterone receptor antagonist (ZK 137. 316). Biol Reprod 2000 0.88
21 Progestins, progesterone receptor modulators, and progesterone antagonists change VEGF release of endometrial cells in culture. Steroids 2000 0.88
22 The relaxation responses to corticotropin-releasing factor in rat aorta are endothelium dependent and gestationally regulated. Am J Obstet Gynecol 1997 0.87
23 Effect of asoprisnil on uterine proliferation markers and endometrial expression of the tumour suppressor gene, PTEN. Hum Reprod 2009 0.86
24 Progesterone receptor modulators and progesterone antagonists in women's health. Steroids 2000 0.86
25 Endothelium-dependent and -independent mechanisms of vasorelaxation by corticotropin-releasing factor in pregnant rat uterine artery. J Pharmacol Exp Ther 1999 0.86
26 Ripening of the uterine cervix of the guinea-pig after treatment with the progesterone antagonist onapristone (ZK 98.299): an electron microscopic study. Hum Reprod 1989 0.86
27 Reversible suppression of menstruation with progesterone antagonists in rhesus macaques. Hum Reprod 2001 0.85
28 Preterm birth in rats produced by the synergistic action of a nitric oxide inhibitor (NG-nitro-L-arginine methyl ester) and an antiprogestin (onapristone). Am J Obstet Gynecol 1996 0.84
29 Synthesis and biological activity of a novel, highly potent progesterone receptor antagonist. J Med Chem 2000 0.84
30 Expression of receptors for corticotropin-releasing factor in the vasculature of pregnant rats. J Soc Gynecol Investig 2000 0.84
31 Regulation of vascular adaptation during pregnancy and post-partum: effects of nitric oxide inhibition and steroid hormones. Hum Reprod 1996 0.83
32 Changes in cervical resistance and collagen fluorescence during gestation in rats. J Perinat Med 1999 0.83
33 Inducible nitric oxide synthase is present in the rat placenta at the fetal-maternal interface and decreases prior to labour. Mol Hum Reprod 1997 0.83
34 Endometrial and myometrial effects of progesterone antagonists in pregnant guinea pigs. Am J Obstet Gynecol 1987 0.82
35 Low-dose antiprogestin treatment prevents pregnancy in rhesus monkeys and is reversible after 1 year of treatment. Hum Reprod 2003 0.82
36 Chronic treatment of female rhesus monkeys with low doses of the antiprogestin ZK 137 316: establishment of a regimen that permits normal menstrual cyclicity. Hum Reprod 1998 0.82
37 A chronic, low-dose regimen of the antiprogestin ZK 137 316 prevents pregnancy in rhesus monkeys. Hum Reprod 1998 0.82
38 Changes in expression of the nitric oxide synthase isoforms in rat uterus and cervix during pregnancy and parturition. Mol Hum Reprod 1997 0.81
39 Progesterone withdrawal up-regulates vascular endothelial growth factor receptor type 2 in the superficial zone stroma of the human and macaque endometrium: potential relevance to menstruation. J Clin Endocrinol Metab 2000 0.81
40 Steroid regulation of prostaglandin dehydrogenase activity and expression in human term placenta and chorio-decidua in relation to labor. J Clin Endocrinol Metab 1999 0.81
41 Endothelial nitric oxide synthase is differently expressed in human endometrial vessels during the menstrual cycle. Mol Hum Reprod 2000 0.80
42 Expression of MAPkinases (Erk1/2) during decidualization in the rat: regulation by progesterone and nitric oxide. Mol Hum Reprod 2002 0.80
43 Contrasting effects of diethylenetriamine-nitric oxide, a spontaneously releasing nitric oxide donor, on pregnant rat uterine contractility in vitro versus in vivo. Am J Obstet Gynecol 1997 0.80
44 The detection and monitoring of early pregnancy in the vervet monkey (Cercopithecus aethiops) with the use of ultrasound and correlation with reproductive steroid hormones. J Med Primatol 2000 0.80
45 Effect of chronic treatment with 17beta-estradiol and progesterone on endothelium-dependent and endothelium-independent relaxation in isolated aortic rings from ovariectomized rats. Am J Obstet Gynecol 1997 0.79
46 Regulation of connexin26 and connexin43 expression in rat endometrium by ovarian steroid hormones. Biol Reprod 1994 0.79
47 Chronic treatment of cycling rhesus monkeys with low doses of the antiprogestin ZK 137 316: morphometric assessment of the uterus and oviduct. Hum Reprod 1998 0.78
48 The effects of nitric oxide on the contractility of isolated uterine and aortic rings from pregnant rats. Am J Obstet Gynecol 1998 0.78
49 Non-competitive anti-oestrogenic actions of progesterone antagonists in primate endometrium: enhancement of oestrogen and progesterone receptors with blockade of post-receptor proliferative mechanisms. Hum Reprod 1996 0.77
50 Non-competitive anti-oestrogenic activity of progesterone antagonists in primate models. Hum Reprod 1994 0.77
51 Role of nucleotide cyclases in the inhibition of pregnant rat uterine contractions by the openers of potassium channels. Am J Obstet Gynecol 2000 0.77
52 Both soluble guanylate cyclase and particulate guanylate cyclase regulate myometrial contractility. Am J Obstet Gynecol 1998 0.77
53 Chronic progesterone antagonist-estradiol therapy suppresses breakthrough bleeding and endometrial proliferation in a menopausal macaque model. Hum Reprod 2006 0.77
54 Effect of gestational age on in-vitro responses of pregnant rat aorta. Hum Reprod 1998 0.77
55 The effect of an endothelin antagonist on blood pressure in a rat model of preeclampsia. Am J Obstet Gynecol 1999 0.76
56 [Morphologic aspects of cervix ripening produced by progestin antagonists]. Arch Gynecol Obstet 1989 0.75
57 Effects of the progesterone antagonists onapristone (ZK 98 299) and ZK 136 799 on surgically induced endometriosis in intact rats. Hum Reprod 1995 0.75
58 The effect of indomethacin and prostacyclin agonists on blood pressure in a rat model of preeclampsia. Am J Obstet Gynecol 1999 0.75
59 Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception. Am J Obstet Gynecol 1995 0.75
60 [Cytosol estrogen and progesterone receptors in the normal and pathological human uterus and ovaries]. Ginekol Pol 1981 0.75
61 Regulation of term and preterm labour, Castellina, Italy, 28 October-1 November 1997. Placenta 1998 0.75
62 Relaxation kinetics of rat aorta during pregnancy. J Soc Gynecol Investig 1998 0.75
63 Treatment with a progesterone antagonist ZK 98.299 delays endometrial development without blocking ovulation in bonnet monkeys. Contraception 1993 0.75
64 [Effect of artificial ventilation on the level of the prostacyclin metabolite 6-ketoprostaglandin F1 alpha in the plasma of newborn infants]. Ginekol Pol 1987 0.75
65 Termination of normal and pathological pregnancy with Sulprostone. Acta Chir Hung 1986 0.75
66 [Radioimmunologic determination of FSH and LH in the blood of women with the hypothalamic syndrome]. Endokrynol Pol 1979 0.75
67 Surgical procedures and their cost estimates among women with newly diagnosed endometriosis: a US database study. J Med Econ 2011 0.75
68 [Prolactin and estradiol levels during hormone therapy of breast cancer]. Ginekol Pol 1985 0.75
69 A non-surgical technique for the transcervical administration of physiological and pharmacological agents into rat uteri. Acta Endocrinol (Copenh) 1983 0.75
70 Relaxation kinetics of the aorta in N omega-nitro-L-arginine methyl ester-treated pregnant rats. J Soc Gynecol Investig 1999 0.75
71 Inhibition of aromatase activity in human placental microsomes by 13-retro-antiprogestins. Steroids 1995 0.75
72 In vivo effects of corticotropin-releasing factor in pregnant rats. Am J Obstet Gynecol 1998 0.75
73 [Value of cyproterone acetate in the treatment of hirsutism]. Ginekol Pol 1982 0.75
74 [Estrogen and progesterone receptors in normal and pathologic human endometrium]. Endokrynol Pol 1981 0.75
75 [Serum prolactin level and bromoergocriptine therapy in galactorrhea and oligo- or amenorrhea]. Ginekol Pol 1981 0.75
76 [Estrogen and progesterone receptors in uterine myomas]. Endokrynol Pol 1982 0.75
77 [Effect of the prostaglandin Nalador on progesterone and estrogen receptors in the pregnant uterus of guinea pigs]. Ginekol Pol 1985 0.75
78 Distribution of estrogen and progesteron receptors in the uterus: an immunohistochemical study in the immature and adult pseudopregnant rabbit. Histochemistry 1992 0.75
79 Endometrial function in vervet monkeys (Cercopithecus aethiops): morphology, beta3 integrin and insulin-like growth factor binding protein-1 expression during the menstrual cycle and pregnancy in the normal and disrupted endometrium. J Med Primatol 2002 0.75
80 The primary level of gonadotropins and the LH-RH test in hypothalamic syndromes in women. Mater Med Pol 1982 0.75
81 [Endometrial cancer in the light of the studies of the estrogen and progesterone receptors in the cytosol]. Ginekol Pol 1982 0.75
82 [Changes in the levels of sex hormone-binding globulin, estradiol and testosterone in the serum of women with breast cancer during various types of hormone therapy]. Nowotwory 1987 0.75
83 [Radio-immunological determination of testosterone and of sexual hormone binding globulin in plasma of women with hirsutism (author's transl)]. Zentralbl Gynakol 1980 0.75
84 [Effect of treatment with tamoxifen on serum levels of various steroid and protein hormones in women with breast cancer]. Endokrynol Pol 1985 0.75